Document Detail


Cutaneous reactions to propranolol (Inderal).
MedLine Citation:
PMID:  132088     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Six patients wit psoriasiform cutaneous eruptions that developed during long-term therapy with propranolol (Inderal) have been studied. The cutaneous changes closely resembled those seen during treatment with practolol (Eraldin). The duration of treatment before the rash was recognized averaged 10 months, which is about the same latency period as in patients with practolol-induced exanthemas. The exanthemas disappeared gradually within 1-5 weeks after treatment with propranolol had been stopped. In 4 of 5 patients the skin eruptions reappeared within 2-4 days after oral challenge with propranolol. In the fifth patient, who developed a rash after challenge with practolol and severe abdominal colics after challenge with oxprenolol, no further provocation tests with propranolol were attempted. Skin biopsies obtained from 3 patients showed a microscopical picture similar to that seen in practolol exanthemas. The pathogenetic mechanism responsible for these adverse cutaneous reactions is unknown. However, since the possibility exists, that these changes may be caused by blockade of the epidermal beta-receptors, it is recommended that all patients receiving beta-blocking drugs should be examined carefully for similar adverse reactions. Special attention should be drawn to the reversible skin changes, since during treatment with practolol these have often preceded serious complications from other organs.
Authors:
H A Jensen; H I Mikkelsen; S Wadskov; J Sondergaard
Related Documents :
23878538 - Inflammatory markers: c-reactive protein, erythrocyte sedimentation rate, and leukocyte...
19309368 - Enhanced expression of the antimicrobial peptide ll-37 in lesional skin of adults with ...
2494248 - Clinical zinc deficiency during adequate enteral nutrition.
6524338 - Collagen fibres in otosclerosis and in osteogenesis imperfecta tarda. a light and elect...
7963418 - Cyclosporin a increases the biochemical markers of bone remodeling in primary biliary c...
17692378 - Clinical features of chinese patients with behçet's disease.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta medica Scandinavica     Volume:  199     ISSN:  0001-6101     ISO Abbreviation:  Acta Med Scand     Publication Date:  1976  
Date Detail:
Created Date:  1976-08-02     Completed Date:  1976-08-02     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370330     Medline TA:  Acta Med Scand     Country:  SWEDEN    
Other Details:
Languages:  eng     Pagination:  363-7     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Angina Pectoris / drug therapy
Arrhythmias, Cardiac / drug therapy
Drug Eruptions* / pathology
Female
Humans
Hypertension / drug therapy
Male
Middle Aged
Propranolol / adverse effects*,  therapeutic use
Skin / pathology
Chemical
Reg. No./Substance:
525-66-6/Propranolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Phosphorylation of purine and pyrimidine nucleosides by isolated rat liver mitochondria.
Next Document:  Chronic myocardial disease. I. Clinical picture related to long-term prognosis.